APO Research
Talk to an analyst

APO RESEARCH · REPORT

Synthetic Opioids

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Synthetic Opioids Market Outlook and Growth Opportunities 2026

20 December 2025195 pages

Choose your research edition.

Industry ResearchSynthetic Opioids Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Synthetic Opioids Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Synthetic Opioids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Synthetic Opioids Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Synthetic Opioids Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Synthetic Opioids market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Synthetic Opioids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Synthetic Opioids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Synthetic Opioids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Synthetic Opioids market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Synthetic Opioids market include Endo International, Impax Laboratories, Indivior, Janssen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Purdue Pharma, West-Ward Pharmaceuticals, Pfizer and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Synthetic Opioids market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Synthetic Opioids and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Synthetic Opioids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Synthetic Opioids market size, projected growth trends, production technologies, key applications, and end-use industries.

Synthetic Opioids Segment by Company

Endo International

Impax Laboratories

Indivior

Janssen Pharmaceuticals

Mallinckrodt Pharmaceuticals

Purdue Pharma

West-Ward Pharmaceuticals

Pfizer

Mylan

Teva Pharmaceuticals

Synthetic Opioids Segment by Type

Hydrocodone

Oxymorphone

Oxycodone

Meperidine

Methadone

Fentanyl

Synthetic Opioids Segment by Application

Pain Management

De-addiction

Synthetic Opioids Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Synthetic Opioids status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Synthetic Opioids market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Synthetic Opioids significant trends, drivers, influence factors in global and regions.

6. To analyze Synthetic Opioids competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synthetic Opioids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Synthetic Opioids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synthetic Opioids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Synthetic Opioids market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Synthetic Opioids industry.

Chapter 3: Detailed analysis of Synthetic Opioids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Synthetic Opioids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Synthetic Opioids in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Synthetic Opioids Industry Trends Table 2. Synthetic Opioids Industry Drivers Table 3. Synthetic Opioids Industry Opportunities and Challenges Table 4. Synthetic Opioids Industry Restraints Table 5. Global Synthetic Opioids Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Synthetic Opioids Revenue Share by Company (2021-2026) Table 7. Global Synthetic Opioids Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Synthetic Opioids Sales Volume Share by Company (2021-2026) Table 9. Global Synthetic Opioids Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Synthetic Opioids Company Ranking, (2024-2026) & (USD Million) Table 11. Global Synthetic Opioids Key Company Manufacturing Base & Headquarters Table 12. Global Synthetic Opioids Company, Product Type & Application Table 13. Global Synthetic Opioids Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Synthetic Opioids by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Hydrocodone Table 18. Significant Companies of Oxymorphone Table 19. Significant Companies of Oxycodone Table 20. Significant Companies of Meperidine Table 21. Significant Companies of Methadone Table 22. Significant Companies of Fentanyl Table 23. Global Synthetic Opioids Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Synthetic Opioids Sales Volume by Type (2021-2026) & (K Units) Table 25. Global Synthetic Opioids Sales Volume by Type (2027-2032) & (K Units) Table 26. Global Synthetic Opioids Sales Volume Share by Type (2021-2026) Table 27. Global Synthetic Opioids Sales Volume Share by Type (2027-2032) Table 28. Global Synthetic Opioids Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Synthetic Opioids Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Synthetic Opioids Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Synthetic Opioids Sales Value Share by Type (2021-2026) Table 32. Global Synthetic Opioids Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Pain Management Table 34. Significant Companies of De-addiction Table 35. Global Synthetic Opioids Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Synthetic Opioids Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Synthetic Opioids Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Synthetic Opioids Sales Volume Share by Application (2021-2026) Table 39. Global Synthetic Opioids Sales Volume Share by Application (2027-2032) Table 40. Global Synthetic Opioids Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Synthetic Opioids Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Synthetic Opioids Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Synthetic Opioids Sales Value Share by Application (2021-2026) Table 44. Global Synthetic Opioids Sales Value Share by Application (2027-2032) Table 45. Global Synthetic Opioids Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Synthetic Opioids Sales by Region (2021-2026) & (K Units) Table 47. Global Synthetic Opioids Sales Market Share by Region (2021-2026) Table 48. Global Synthetic Opioids Sales by Region (2027-2032) & (K Units) Table 49. Global Synthetic Opioids Sales Market Share by Region (2027-2032) Table 50. Global Synthetic Opioids Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Synthetic Opioids Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Synthetic Opioids Sales Value Share by Region (2021-2026) Table 53. Global Synthetic Opioids Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Synthetic Opioids Sales Value Share by Region (2027-2032) Table 55. Global Synthetic Opioids Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Synthetic Opioids Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Synthetic Opioids Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Synthetic Opioids Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Synthetic Opioids Sales by Country (2021-2026) & (K Units) Table 60. Global Synthetic Opioids Sales Market Share by Country (2021-2026) Table 61. Global Synthetic Opioids Sales by Country (2027-2032) & (K Units) Table 62. Global Synthetic Opioids Sales Market Share by Country (2027-2032) Table 63. Global Synthetic Opioids Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Synthetic Opioids Sales Value Market Share by Country (2021-2026) Table 65. Global Synthetic Opioids Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Synthetic Opioids Sales Value Market Share by Country (2027-2032) Table 67. Endo International Company Information Table 68. Endo International Business Overview Table 69. Endo International Synthetic Opioids Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Endo International Synthetic Opioids Product Portfolio Table 71. Endo International Recent Development Table 72. Impax Laboratories Company Information Table 73. Impax Laboratories Business Overview Table 74. Impax Laboratories Synthetic Opioids Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Impax Laboratories Synthetic Opioids Product Portfolio Table 76. Impax Laboratories Recent Development Table 77. Indivior Company Information Table 78. Indivior Business Overview Table 79. Indivior Synthetic Opioids Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Indivior Synthetic Opioids Product Portfolio Table 81. Indivior Recent Development Table 82. Janssen Pharmaceuticals Company Information Table 83. Janssen Pharmaceuticals Business Overview Table 84. Janssen Pharmaceuticals Synthetic Opioids Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Janssen Pharmaceuticals Synthetic Opioids Product Portfolio Table 86. Janssen Pharmaceuticals Recent Development Table 87. Mallinckrodt Pharmaceuticals Company Information Table 88. Mallinckrodt Pharmaceuticals Business Overview Table 89. Mallinckrodt Pharmaceuticals Synthetic Opioids Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Mallinckrodt Pharmaceuticals Synthetic Opioids Product Portfolio Table 91. Mallinckrodt Pharmaceuticals Recent Development Table 92. Purdue Pharma Company Information Table 93. Purdue Pharma Business Overview Table 94. Purdue Pharma Synthetic Opioids Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Purdue Pharma Synthetic Opioids Product Portfolio Table 96. Purdue Pharma Recent Development Table 97. West-Ward Pharmaceuticals Company Information Table 98. West-Ward Pharmaceuticals Business Overview Table 99. West-Ward Pharmaceuticals Synthetic Opioids Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. West-Ward Pharmaceuticals Synthetic Opioids Product Portfolio Table 101. West-Ward Pharmaceuticals Recent Development Table 102. Pfizer Company Information Table 103. Pfizer Business Overview Table 104. Pfizer Synthetic Opioids Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Pfizer Synthetic Opioids Product Portfolio Table 106. Pfizer Recent Development Table 107. Mylan Company Information Table 108. Mylan Business Overview Table 109. Mylan Synthetic Opioids Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Mylan Synthetic Opioids Product Portfolio Table 111. Mylan Recent Development Table 112. Teva Pharmaceuticals Company Information Table 113. Teva Pharmaceuticals Business Overview Table 114. Teva Pharmaceuticals Synthetic Opioids Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Teva Pharmaceuticals Synthetic Opioids Product Portfolio Table 116. Teva Pharmaceuticals Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Synthetic Opioids Distributors List Table 120. Synthetic Opioids Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Synthetic Opioids Product Image Figure 2. Global Synthetic Opioids Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Synthetic Opioids Sales Value (2021-2032) & (US$ Million) Figure 4. Global Synthetic Opioids Sales (2021-2032) & (K Units) Figure 5. Global Synthetic Opioids Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Synthetic Opioids Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Hydrocodone Image Figure 10. Oxymorphone Image Figure 11. Oxycodone Image Figure 12. Meperidine Image Figure 13. Methadone Image Figure 14. Fentanyl Image Figure 15. Global Synthetic Opioids Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Synthetic Opioids Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Synthetic Opioids Sales Volume Share by Type (2021-2032) Figure 18. Global Synthetic Opioids Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Synthetic Opioids Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Synthetic Opioids Sales Value Share by Type (2021-2032) Figure 21. Pain Management Image Figure 22. De-addiction Image Figure 23. Global Synthetic Opioids Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Synthetic Opioids Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Synthetic Opioids Sales Volume Share by Application (2021-2032) Figure 26. Global Synthetic Opioids Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Synthetic Opioids Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Synthetic Opioids Sales Value Share by Application (2021-2032) Figure 29. Global Synthetic Opioids Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Synthetic Opioids Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Synthetic Opioids Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Synthetic Opioids Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Synthetic Opioids Sales Value (2021-2032) & (US$ Million) Figure 34. North America Synthetic Opioids Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Synthetic Opioids Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Synthetic Opioids Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Synthetic Opioids Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Synthetic Opioids Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Synthetic Opioids Sales Value (2021-2032) & (US$ Million) Figure 40. South America Synthetic Opioids Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Synthetic Opioids Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Synthetic Opioids Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Synthetic Opioids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Synthetic Opioids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Synthetic Opioids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Synthetic Opioids Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Synthetic Opioids Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Hydrocodone
  • Oxymorphone
  • Oxycodone
  • Meperidine
  • Methadone
  • Fentanyl
Applications
  • Pain Management
  • De-addiction
Companies covered
  • Endo International
  • Impax Laboratories
  • Indivior
  • Janssen Pharmaceuticals
  • Mallinckrodt Pharmaceuticals
  • Purdue Pharma
  • West-Ward Pharmaceuticals
  • Pfizer
  • Mylan
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Synthetic Opioids Sales Value (2021-2032)
  4. 1.2.2 Global Synthetic Opioids Sales Volume (2021-2032)
  5. 1.2.3 Global Synthetic Opioids Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Synthetic Opioids Market Dynamics
  1. 2.1 Synthetic Opioids Industry Trends
  2. 2.2 Synthetic Opioids Industry Drivers
  3. 2.3 Synthetic Opioids Industry Opportunities and Challenges
  4. 2.4 Synthetic Opioids Industry Restraints
3 Synthetic Opioids Market by Company
  1. 3.1 Global Synthetic Opioids Company Revenue Ranking in 2025
  2. 3.2 Global Synthetic Opioids Revenue by Company (2021-2026)
  3. 3.3 Global Synthetic Opioids Sales Volume by Company (2021-2026)
  4. 3.4 Global Synthetic Opioids Average Price by Company (2021-2026)
  5. 3.5 Global Synthetic Opioids Company Ranking (2024-2026)
  6. 3.6 Global Synthetic Opioids Company Manufacturing Base and Headquarters
  7. 3.7 Global Synthetic Opioids Company Product Type and Application
  8. 3.8 Global Synthetic Opioids Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Synthetic Opioids Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Synthetic Opioids Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Synthetic Opioids Market by Type
  1. 4.1 Synthetic Opioids Type Introduction
  2. 4.1.1 Hydrocodone
  3. 4.1.2 Oxymorphone
  4. 4.1.3 Oxycodone
  5. 4.1.4 Meperidine
  6. 4.1.5 Methadone
  7. 4.1.6 Fentanyl
  8. 4.2 Global Synthetic Opioids Sales Volume by Type
  9. 4.2.1 Global Synthetic Opioids Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Synthetic Opioids Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Synthetic Opioids Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Synthetic Opioids Sales Value by Type
  13. 4.3.1 Global Synthetic Opioids Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Synthetic Opioids Sales Value by Type (2021-2032)
  15. 4.3.3 Global Synthetic Opioids Sales Value Share by Type (2021-2032)
5 Synthetic Opioids Market by Application
  1. 5.1 Synthetic Opioids Application Introduction
  2. 5.1.1 Pain Management
  3. 5.1.2 De-addiction
  4. 5.2 Global Synthetic Opioids Sales Volume by Application
  5. 5.2.1 Global Synthetic Opioids Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Synthetic Opioids Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Synthetic Opioids Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Synthetic Opioids Sales Value by Application
  9. 5.3.1 Global Synthetic Opioids Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Synthetic Opioids Sales Value by Application (2021-2032)
  11. 5.3.3 Global Synthetic Opioids Sales Value Share by Application (2021-2032)
6 Synthetic Opioids Regional Sales and Value Analysis
  1. 6.1 Global Synthetic Opioids Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Synthetic Opioids Sales by Region (2021-2032)
  3. 6.2.1 Global Synthetic Opioids Sales by Region: 2021-2026
  4. 6.2.2 Global Synthetic Opioids Sales by Region (2027-2032)
  5. 6.3 Global Synthetic Opioids Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Synthetic Opioids Sales Value by Region (2021-2032)
  7. 6.4.1 Global Synthetic Opioids Sales Value by Region: 2021-2026
  8. 6.4.2 Global Synthetic Opioids Sales Value by Region (2027-2032)
  9. 6.5 Global Synthetic Opioids Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Synthetic Opioids Sales Value (2021-2032)
  12. 6.6.2 North America Synthetic Opioids Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Synthetic Opioids Sales Value (2021-2032)
  15. 6.7.2 Europe Synthetic Opioids Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Synthetic Opioids Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Synthetic Opioids Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Synthetic Opioids Sales Value (2021-2032)
  21. 6.9.2 South America Synthetic Opioids Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Synthetic Opioids Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Synthetic Opioids Sales Value Share by Country, 2025 VS 2032
7 Synthetic Opioids Country-level Sales and Value Analysis
  1. 7.1 Global Synthetic Opioids Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Synthetic Opioids Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Synthetic Opioids Sales by Country (2021-2032)
  4. 7.3.1 Global Synthetic Opioids Sales by Country (2021-2026)
  5. 7.3.2 Global Synthetic Opioids Sales by Country (2027-2032)
  6. 7.4 Global Synthetic Opioids Sales Value by Country (2021-2032)
  7. 7.4.1 Global Synthetic Opioids Sales Value by Country (2021-2026)
  8. 7.4.2 Global Synthetic Opioids Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Synthetic Opioids Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Synthetic Opioids Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Synthetic Opioids Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Synthetic Opioids Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Synthetic Opioids Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Synthetic Opioids Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Synthetic Opioids Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Synthetic Opioids Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Synthetic Opioids Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Synthetic Opioids Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Synthetic Opioids Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Synthetic Opioids Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Synthetic Opioids Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Synthetic Opioids Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Synthetic Opioids Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Synthetic Opioids Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Synthetic Opioids Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Synthetic Opioids Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Synthetic Opioids Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Synthetic Opioids Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Synthetic Opioids Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Synthetic Opioids Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Synthetic Opioids Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Synthetic Opioids Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Synthetic Opioids Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Synthetic Opioids Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Synthetic Opioids Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Synthetic Opioids Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Synthetic Opioids Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Synthetic Opioids Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Endo International
  2. 8.1.1 Endo International Company Information
  3. 8.1.2 Endo International Business Overview
  4. 8.1.3 Endo International Synthetic Opioids Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Endo International Synthetic Opioids Product Portfolio
  6. 8.1.5 Endo International Recent Developments
  7. 8.2 Impax Laboratories
  8. 8.2.1 Impax Laboratories Company Information
  9. 8.2.2 Impax Laboratories Business Overview
  10. 8.2.3 Impax Laboratories Synthetic Opioids Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Impax Laboratories Synthetic Opioids Product Portfolio
  12. 8.2.5 Impax Laboratories Recent Developments
  13. 8.3 Indivior
  14. 8.3.1 Indivior Company Information
  15. 8.3.2 Indivior Business Overview
  16. 8.3.3 Indivior Synthetic Opioids Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Indivior Synthetic Opioids Product Portfolio
  18. 8.3.5 Indivior Recent Developments
  19. 8.4 Janssen Pharmaceuticals
  20. 8.4.1 Janssen Pharmaceuticals Company Information
  21. 8.4.2 Janssen Pharmaceuticals Business Overview
  22. 8.4.3 Janssen Pharmaceuticals Synthetic Opioids Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Janssen Pharmaceuticals Synthetic Opioids Product Portfolio
  24. 8.4.5 Janssen Pharmaceuticals Recent Developments
  25. 8.5 Mallinckrodt Pharmaceuticals
  26. 8.5.1 Mallinckrodt Pharmaceuticals Company Information
  27. 8.5.2 Mallinckrodt Pharmaceuticals Business Overview
  28. 8.5.3 Mallinckrodt Pharmaceuticals Synthetic Opioids Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mallinckrodt Pharmaceuticals Synthetic Opioids Product Portfolio
  30. 8.5.5 Mallinckrodt Pharmaceuticals Recent Developments
  31. 8.6 Purdue Pharma
  32. 8.6.1 Purdue Pharma Company Information
  33. 8.6.2 Purdue Pharma Business Overview
  34. 8.6.3 Purdue Pharma Synthetic Opioids Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Purdue Pharma Synthetic Opioids Product Portfolio
  36. 8.6.5 Purdue Pharma Recent Developments
  37. 8.7 West-Ward Pharmaceuticals
  38. 8.7.1 West-Ward Pharmaceuticals Company Information
  39. 8.7.2 West-Ward Pharmaceuticals Business Overview
  40. 8.7.3 West-Ward Pharmaceuticals Synthetic Opioids Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 West-Ward Pharmaceuticals Synthetic Opioids Product Portfolio
  42. 8.7.5 West-Ward Pharmaceuticals Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Synthetic Opioids Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Synthetic Opioids Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Mylan
  50. 8.9.1 Mylan Company Information
  51. 8.9.2 Mylan Business Overview
  52. 8.9.3 Mylan Synthetic Opioids Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Mylan Synthetic Opioids Product Portfolio
  54. 8.9.5 Mylan Recent Developments
  55. 8.10 Teva Pharmaceuticals
  56. 8.10.1 Teva Pharmaceuticals Company Information
  57. 8.10.2 Teva Pharmaceuticals Business Overview
  58. 8.10.3 Teva Pharmaceuticals Synthetic Opioids Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Teva Pharmaceuticals Synthetic Opioids Product Portfolio
  60. 8.10.5 Teva Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Synthetic Opioids Value Chain Analysis
  2. 9.1.1 Synthetic Opioids Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Synthetic Opioids Sales Mode & Process
  6. 9.2 Synthetic Opioids Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Synthetic Opioids Distributors
  9. 9.2.3 Synthetic Opioids Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst